NASDAQ:BLUE - bluebird bio, Inc.
$135.61
 $1.32
+0.98%
1:50PM EDT
2019-02-15
bluebird bio, Inc. is a clinical-stage biotechnology company. The Company is focused on developing gene therapies for severe diseases and cancer. With its lentiviral-based gene therapy and gene editing capabilities, it has built an integrated product platform with various applications in these areas. The Company's clinical programs in severe genetic diseases include its LentiGlobin product candidate to treat transfusion-dependent b-thalassemia and to treat severe sickle cell disease (SCD) and its Lenti-D product candidate to treat cerebral adrenoleukodystrophy (CALD). Its programs in oncology focuses on developing T cell-based immunotherapies, including chimeric antigen receptor (CAR) and T cell receptor (TCR) T cell therapies. bb2121, its lead product candidate in oncology, is a CAR T cell product candidate for the treatment of multiple myeloma. It also has discovery research programs utilizing megaTALs/homing endonuclease gene editing technologies for use across its pipeline. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  BLUE     avg for
industry  
  avg for
sector  
42 stocks weight:  196. 93   0. 00   0. 00  
42 stocks rank:  915. 00   1. 86 K 1. 09 K
# analyst opinions:  18. 00   14. 92   14. 43  
mean recommendation:  1. 90   1. 91   1. 93  

quick ratio:  12. 92   5. 37   1. 81  
current ratio:  13. 11   5. 69   2. 19  

target price low:  120. 00   88. 97   117. 82  
target price avg:  179. 39   115. 19   141. 96  
target price high:  284. 00   143. 40   163. 16  
1-yr high:  233. 05   124. 30   142. 77  
last close:  134. 29   101. 85   127. 84  
50-day avg:  115. 73   98. 27   122. 46  
200-day avg:  145. 43   99. 72   122. 70  
1-yr low:  91. 25   78. 19   100. 16  
volume:  302. 02 K 2. 38 M 4. 64 M
50-day avg volume:  666. 95 K 3. 31 M 4. 94 M
200-day avg volume:  738. 00 K 3. 23 M 4. 28 M

1-day return:  -0. 98 % 0. 22 % 0. 48 %
this week return:  2. 71 % 1. 77 % 2. 01 %
12-wk return:  9. 95 % 6. 56 % 3. 33 %
52-wk return:  -34. 74 % -2. 23 % 14. 35 %

enterprise value (EV):  5. 86 B 55. 17 B 104. 51 B
market cap:  7. 34 B 49. 01 B 96. 46 B
EBITDA:  -515. 47 M 4. 82 B 7. 18 B
enterprise multiple (EV/EBITDA):  -11. 36   -91. 79   2. 29  
enterprise/revenue (EV/R):  148. 28   29. 84   23. 39  
total revenue:  39. 50 M 11. 28 B 40. 22 B
total debt:  155. 03 M 13. 73 B 16. 57 B
debt/equity:  7. 75   258. 01   110. 73  
net income (common):  -523. 83 M 2. 37 B 3. 58 B

shares outstanding:  54. 69 M 607. 99 M 1. 22 B
shares:  54. 45 M 605. 53 M 1. 15 B
shares short:  5. 30 M 11. 62 M 12. 55 M
shares short prior month:  5. 07 M 11. 95 M 13. 44 M
short ratio:  8. 53   4. 82   3. 10  
short % of float:  16. 88 % 6. 19 % 2. 82 %
total cash/share:  31. 00   12. 02   11. 46  
total cash:  1. 70 B 7. 41 B 7. 37 B
free cash flow:  -234. 33 M 95. 99 M 2. 04 B
operating cash flow:  -379. 07 M 164. 74 M 3. 04 B

book value:  36. 59   14. 43   28. 26  
price/book:  3. 67   -1. 57   -2. 97  
gross profits:  -239. 14 M 8. 28 B 18. 09 B
operating margins:  -1345. 99 % -458. 01 % -642. 83 %
EBITDA margins:  0. 00 % 13. 81 % 22. 47 %
profit margins:  0. 00 % 6. 57 % 9. 92 %
gross margins:  0. 00 % 49. 33 % 54. 53 %

1-yr max volatility:  13. 47 % --- ---
1-yr mean volatility:  -0. 11 % 0. 01 % 0. 06 %

1-yr EPS:  -10. 48   3. 03   4. 09  
forward EPS:  -11. 52   4. 33   6. 99  
P/E:  -12. 82   6. 11   26. 91  
forward P/E:  -11. 77   8. 38   10. 48  
PE/G:  -0. 26   0. 37   5. 61  
growth:  49. 50 % 683. 72 % 104. 79 %
earnings high:  -2. 55   1. 27   1. 66  
earnings avg:  -2. 86   1. 01   1. 53  
earnings low:  -3. 20   0. 76   1. 40  
revenue high:  12. 00 M 2. 86 B 11. 19 B
revenue avg:  8. 12 M 2. 78 B 10. 84 B
revenue low:  -0. 00   2. 67 B 10. 64 B
return on assets:  -17. 69 % -3. 27 % 3. 81 %
return on equity:  -33. 34 % 107. 48 % 27. 82 %
revenue growth:  49. 50 % 648. 36 % 97. 70 %
revenue/share:  0. 79   14. 68   59. 83  

beta (1yr vs S&P500):  1. 25   1. 21   0. 93  
sharpe (1yr):  -0. 52   0. 06   0. 98  

held % insiders:  0. 48 % 6. 46 % 3. 21 %
held % institutions:  113. 47 % 79. 10 % 70. 01 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-14 : BLUE
.    + 1.109 =         1.109 :: INITIAL WEIGHT
.  + 161.653 =       162.762 :: inverse volume-to-price addition
.  + 250.574 =       413.336 :: spline projection addition
. + 1208.453 =       1621.79 :: notable performance addition
.  - 132.479 =      1489.311 :: poor performance penalty
.    x 0.798 =      1188.137 :: one-year gains+dividend factor
.    x 7.314 =      8690.074 :: 13 weeks' performance factor
.    x 1.492 =     12969.838 :: industry recommendation factor
.    x 2.583 =     33495.368 :: symbol recommendation factor
.    x 3.602 =    120642.308 :: EV/R factor
.    x 0.998 =    120428.916 :: return on assets factor
.    x 0.997 =     120027.37 :: return on equity factor
.     x 2.24 =    268875.856 :: revenue growth factor
.    x 2.302 =    618924.485 :: current ratio factor
.    x 1.041 =    644359.111 :: quick ratio factor
.    x 1.057 =    681082.793 :: short ratio factor
.    x 2.037 =   1387160.833 :: price-to-book factor
.    x 1.015 =   1407837.402 :: debt-to-equity factor
.    x 1.158 =    1629880.38 :: 5-day avg > 50-day avg
.    x 2.089 =   3404268.625 :: P/E weight
.    x 1.402 =    4772480.51 :: PE/G factor
.    x 1.609 =   7676714.218 :: beta factor
.     x 0.52 =   3995715.445 :: sharpe factor
.    x 0.967 =    3865372.11 :: target low factor
.    x 1.193 =   4612055.496 :: target mean factor
.    x 1.106 =   5099020.882 :: target high factor
.    x 1.066 =   5433581.954 :: industry 12-weeks return
.      x 1.0 =   5433384.526 :: overall "drift" factor
.    x 0.865 =   4701512.019 :: largest single-day jump factor
.     x 1.01 =   4748477.253 :: mean volatility factor
.    x 1.097 =   5211310.195 :: 42-day mean volatility factor
.      x 1.0 =   5211659.992 :: factor hist industry gain for week 06
.    x 1.465 =   7637663.051 :: upcoming earnings report factor
.   cubeRoot =       196.934 :: reduced for readability
.                    196.934 :: FINAL WEIGHT for NASDAQ:BLUE


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org